房间隔缺损介入治疗现状与未来|房间隔缺损介入治疗研究

[参考文献][1]　KingTD,MillsNL.Secundumatrialseptaldefects:nonoperativeclosureduringcardiaccatheterization[J].JAMA,1976,235:2506-2509.[2]　RashkindWJ.Transcathetertreatmentofcongenitalheartdisease[J].Circulation,1993,67:711-716.[3]　LockJE,RomeJJ,DavisR,etal.Transcatheterclosureofatrialseptaldefect:experimentstudy[J].Circulation,1989,79:1091-1099.[4]　JustoRN,NykanenDG,BoutinC,etal.Clinicalimpactoftranscatheterclosureofsecundumatrialseptaldefectswiththedoubleumbrelladevice[J].AmJCardiol,1996,77:889-892.[5]　KaulitaR,PaulT,HausdorfG.Extendingthelimitsoftranscatheterclosureofatrialdefectswiththedoubleumbrelladevice（CardioSEAL）[J].Heart,1998,80:54-59.[6]　AlanWN,AmyB,KimbG,etal.DeviceclosureratesofsimpleatrialseptaldefectsoptimizedbytheSTARFlexdevice[J].JAmCollCardiol,2006,48:538-544.[7]　MasuraJ,GavoraP,FormanekA,etal.Transcatheterclosureofsecundumatrialseptaldefectsusingthenewself2centeringAmplatzerseptaloccluder:initialhumanexperience[J].CathetCardiovascDiagn,1997,42:388-393.[8]　LatsonLA,ZahnEM,WilsonN.Helexseptaloccluderforclosureofatrialseptaldefects[J].CurrIntervCardiolRep,2000,2:268-273.[9]　ZahnEM,WilsonN,CutrightW,etal.DevelopmentandtestingoftheHelexseptaloccluder,anewexpandedpolytetrafluoroehyleneatrialdefectocclusionsystem[J].Circulation,2001,104:711-716.[10]　ThomasKJ,LarryAL,ZahnE,etal.ResultsoftheU.S.multicenterpivotalstudyoftheHelexseptaloccluderforpercutaneousclosureofsecundumatrialseptaldefects[J].JAmCollCardiol,2007,49:2215-2221.[11]　JuxC,BertramH,WohlseinP,etal.Interventionalatrialseptaldefectclosureusingatotallybioresoorbableoccludermatrix:developmentandpreclinicalevaluationoftheBioSTARdevice[J].JAmCollCardiol,2006,48:161-169.[12]　MichaelJ,DaviadHS,JosephV,etal.BioSTARevaluationstudy（BEST）,aprospective,multicenter,phaseIclinicaltrialtoevaluationthefeasibility,efficacy,andsafetyoftheBioSTARbioabsorbableseptalrepairimplantfortheclosureofatrial2levelshunts[J].Circulation,2006,114:1962-1967.[13]　SteeleP,FusterV,CohenM,etal.Isolatedatrialseptaldefectwithpulmonaryvascularobstructivedisease:long2termfollow2upandpredictionofoutcomeaftersurgicalcorrection[J].Circulation,1987,76:1037-1042.[14]　JoseS,AlfonsoM,MiguelR,etal.Effectivenessofpercutaneousdeviceocclusionforatrialseptaldefectinadultpatientswithpulmonaryhypertension[J].AmHeartJ,2002,144:887-880.[15]　SchubertS,PetersB,Abdul2khaliqH,etal.Leftventricularconditioningintheelderlypatienttopreventcongestiveheartfailureaftertranscatheterclosureofatrialseptaldefect[J].CatheterCardiovascInterv,2005,61:333-337.[16]　HolzerR,CaoQL,ZiyadM,etal.Closureofamoderatelylargeatrialseptaldefectwithaself2fabricatedfenestratedAmplatzerseptaloccluderinan852yearoldpatientwithreduceddiastolicelasticityofleftventricle[J].CatheterCardiovascInterv,2005,64:513-517.[17]　MarcoP,GiuseppeS,CasoP,etal.Globalandregionalleftventricularfunctioninpatientundergoingtranscatheterclosureofsecundumatrialseptaldefect[J].AmJCardiol,2005,96:439-442.[18]　KhairyP,O’DonnellCP,LandzbergMJ.Transcatheterclosureversusmedicaltherapyofpatentforamenovaleandpresumedparadoxicalthromboemboli:asystematicreview[J].AnnInternMed,2003,139:753-760.[19]　KrumsdorfU,OstermayerS,BillingerK,etal.Incidenceandclinicalcourseofthrombusformationonatrialseptaldefectandpatientforamenovaleclosuredevicesin1000consecutivepatients[J].JAmCollCardiol,2004,43:302-309.[20]　KnirschW,Dodge2KhatamiA,BalmerC,etal.Aorticsinus2leftatrialfistulaafterinterventionalclosureofatrialseptaldefect[J].CatheterCardiovascInterv,2005,66:10-13.[21]　AminZ,HijaziZM,BassJL,etal.ErosionofAmplatzerseptaloccluderdeviceafterclosureofsecundumatrialseptaldefects:reviewofregistryofcomplicationsandrecommendationstominimizefuturerisk[J].CatheterCardiovascInterv,2004,63:496-502.[22]　SudaK,RaboissonMJ,PietteE,etal.ReversibleatrioventricularblockassociatedwithclosureofatrialseptaldefectsusingtheAmplatzerdevice[J].JAmCollCardiol,2004,43:1677-1682.[23]　SchwerzmannM,NedeltchevK,MeierB.Patentforamenovaleclosure:anewtherapyformigraine[J].CatheterCardiovascInterv,2007,69:277-284.[24]　JosepRC,SophieM,AlierM,etal.Incidence,timing,andpredictivefactorsofnew2onsetmigraineheadacheattactaftertransscatheterclosureofatrialseptaldefectorpatentforamenovale[J].AmJCardiol,2008,101:688-692.[25]　KedhiE,VermeerschTP.Theinfluenceofthepercutaneousclosureofatrialseptaldefectontheoccurrenceofmigraine[J].EurHeartJ,2005,26:2746-2747.[26]　RiesMW,KampmannC,RupprechtHJ,etal.NickelreleaseafterimplantationoftheAmplatzeroccluder[J].AmHeartJ,2003,145:737-741.[27]　WertmanB,AzarbalB,RiedlM,etal.Adverseeventsassociatedwithnickelallergyinpatientsundergoingpercutaneousatrialseptaldefectorpatentforamenovaleclosure[J].JAmCollCardiol,2006,47:1226-1227.